NDC 51808-213

Glucoheptonate

Glucoheptonate

Glucoheptonate is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Anazaohealth Corporation. The primary component is Calcium Gluceptate.

Product ID51808-213_fb2f24ff-01b1-4afe-9a24-dfa98fa1f047
NDC51808-213
Product TypeHuman Prescription Drug
Proprietary NameGlucoheptonate
Generic NameGlucoheptonate
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2012-05-23
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameAnazaoHealth Corporation
Substance NameCALCIUM GLUCEPTATE
Active Ingredient Strength50 mg/1
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 51808-213-01

1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 KIT (51808-213-01)
Marketing Start Date2012-05-23
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51808-213-01 [51808021301]

Glucoheptonate INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryUnapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-05-23
Inactivation Date2019-11-27

Drug Details

Active Ingredients

IngredientStrength
CALCIUM GLUCEPTATE50 mg/1

OpenFDA Data

SPL SET ID:ac9f0c4b-d0b0-489a-896d-a92d40f21b7e
Manufacturer
UNII

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.